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Introduction
According to the U.S. Depart-ment of Health and Human Ser-vices, there are currently 1,177 
Health Professional Shortage Areas 
(HPSAs) in California, and about forty-
four percent of them (518 HPSAs) are 
in primary care.1 The shortage of pri-
mary care physicians (PCPs) is a chal-
lenge to providing high-quality health 
care in California, and this shortage 
is anticipated to continue posing 
problems in the near future as the 
national health care reforms come into 
force. In addition, the Robert Graham 
Center projects that “California will 
need an additional 8,243 primary care 
physicians by 2030, a 32% increase 
compared to the state’s current (as of 
2010) 25,153 PCP workforce.2”
The recent passing of Senate Bill 
(SB) 493 attempts to tackle this pro-
vider shortage problem in California by 
declaring pharmacists as health care 
providers and authorizing new roles 
for them, optimizing the patient and 
pharmaceutical care provided for the 
public. Pharmacists are highly trained 
but under-utilized professionals on the 
health care team, who possess the 
knowledge and capabilities that can 
help alleviate the consequences of 
this primary care physician shortage in 
California. In addition to relieving the 
provider shortage problem, one of the 
goals of the pharmacy profession is to 
move “away from the distributive and 
business aspects and [move] toward 
meeting the needs of patients in their 
use of medications.3” For many years, 
pharmacists in California struggled 
to reach this goal, as they were not 
recognized as health care providers in 
statute until now. 
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Abstract
The recent passing of Senate Bill (SB) 493 – effective on January 1, 2014 – addresses a primary care provider short-
age in California by declaring pharmacists as health care providers and authorizing new roles for them in patient care. 
The aims of this pilot study were to examine California registered pharmacists’ awareness and knowledge of the 
expanded authorities granted by SB 493 as well as to assess their perception of their own readiness to exercise these 
new authorities. A cross-sectional, observational study was designed, and a 40-question survey was administered 
electronically through Qualtrics to adjunct faculty, clinical faculty, and alumni of Touro University California College of 
Pharmacy. All participants were aware of this new legislation. Through their responses to Likert-scale questions, phar-
macists’ self-perceived readiness for each new authority was discovered. A Kruskal-Wallis test revealed no statistically 
significant difference among the three subgroups’ self-perceived readiness to exercise most of the new authorities, 
except initiating and administering vaccinations independently to those older than three years old without a physician’s 
collaborative practice protocol (p = 0.0123). The lower degree of self-perceived readiness to provide immunizations 
independently reported by adjunct faculty might have been due to not being certified as immunizers, reflecting the 
need to be educated on administration of vaccinations.
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This bill expands the types of phar-
macy settings in which certain ser-
vices can be performed, services that 
previously could only be performed in 
some specific care settings (e.g., inpa-
tient). With the establishment of SB 
493, pharmacists in California will be 
able to integrate pharmacy practices 
more efficiently and effectively into 
a multidisciplinary health care team 
with an increased access to health 
care records.4,5 SB 493 provides a 
new platform for the advancement 
of the pharmacy profession in Cali-
fornia and empowers pharmacists 
to provide more clinical services in 
conjunction with other health care 
providers. The following indicates 
the newly granted authorities in 
detail:4,5 
•	 Administering prescribed 
drugs and biologics;
•	 Furnishing self-administered 
hormonal contraception 
(requiring additional training);
•	 Furnishing nicotine replace-
ment products (requiring addi-
tional training);
•	 Furnishing prescription travel 
medications not requiring a 
diagnosis (following recom-
mendations from the Cen-
ters for Disease Control and 
Prevention);
•	 Immunizing without a physi-
cian’s protocol to those who 
are at least three years old 
(following guidelines from 
the Advisory Committee on 
Immunization Practices and 
Centers for Disease Control 
and Prevention); 
•	 Ordering and interpreting lab 
results to ensure safety and 
efficacy of drug therapy;
•	 Reviewing patient progress 
in a multidisciplinary team 
with an increased access to 
patient medical records;
•	 Educating patients on drug 
therapies, disease manage-
ment, and disease preven-
tion.
In addition to granting new author-
ities to registered pharmacists, this 
bill also establishes a new category 
of pharmacists – Advanced Practice 
Pharmacists (APPs) – to recognize 
those who have met at least two of 
the following criteria:4,5
•	 Earning a certification 
relevant to pharmacy prac-
tice from an organization 
recognized by the Accredita-
tion Council for Pharmacy 
Education or by the Board of 
Pharmacy;
•	 Completing a postgradu-
ate residency program from 
an accredited postgraduate 
institution, including at least 
50 percent of the time focus-
ing on providing direct patient 
care service with an interdis-
ciplinary team;
•	 Having provided clinical 
services for at least one 
year under a collaborative 
practice protocol associated 
with a physician, an advanced 
practice pharmacist, a drug 
therapy management pharma-
cist, or a health system.
 
Since SB 493 
provided all regis-
tered pharmacists 
across the state 
of California with 
new authorities 
starting January 
1, 2014, no study 
has been done to 
reveal pharma-
cists’ awareness 
of, knowledge 
about, and self-
perceived readi-
ness for the new authorities. These 
newly granted authorities deal with 
many areas of pharmacy practice, 
providing California registered phar-
macists more clinical responsibili-
ties to serve the public. As a result, 
the goal of the study is to discover 
how well pharmacists have been 
prepared for their new responsibili-
ties from their previous education, 
training, and work experience so that 
appropriate actions can be identified 
to assist pharmacists to execute the 
new tasks more confidently. The 
objectives for this pilot study were: 
(1) to examine California registered 
pharmacists’ awareness and knowl-
edge of their expanded authorities 
granted by SB 493; (2) to assess 
their perception of their own readi-
ness to exercise these new authori-
ties; and (3) to identify actions to 
further equip pharmacists to respond 
to SB 493. 
Methods
A cross-sectional, observational 
study design was implemented, 
employing a 40-question survey. 
This survey was developed using 
the Qualtrics web-based survey pro-
gram. Survey items included demo-
graphic characteristics, awareness 
and knowledge of the new authorities 
and provisions of SB 493, interest in 
becoming an Advanced Practice Phar-
macist, readiness for new authorities 
provided by SB 493, and thoughts on 
barriers to of implementing SB 493. 
In addition, an open-ended comment 
section was provided to collect study 
participants’ thoughts and ideas on 
this new law that were not captured 
by the survey tool (See Appendix: 
Survey Instrument for the complete 
survey). This survey tool, includ-
ing informed consent, has been 
approved by the Touro University 
California Institutional Review 
Board.
This pilot survey was distributed 
electronically in January and Feb-
ruary of 2014 to adjunct faculty, 
clinical faculty, and alumni of the 
Touro University California College 
of Pharmacy, who were also reg-
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Table 1. Demographic Characteristics
Adjunct Faculty Clinical Faculty Alumni All
N 28 15 8 51
Average Years of Pharmacy Practice Experience
(% Responding)
20.9
(89%)
11.7
(100%)
1.2
(100%)
11.3
(94%)
Practice Sites
Academia - 27% - 8%
Ambulatory Care 18% 33% 13% 22%
Community Pharmacy 14% 20% 25% 18%
Inpatient Pharmacy 43% 20% 50% 37%
Other 25% - 13% 16%
Highest Level of Pharmacy Education & Training
Earned a PharmD and/or obtained post-PharmD 
training 
96% 100% 100% 98%
Earned a BS degree in pharmacy 4% - - 2%
Geographical Regions
Northern California 75% 100% 88% 84%
Central California 7% - - 4%
Southern California 18% - 13% 12%
istered pharmacists in California. 
After meeting the aforementioned 
inclusion criteria, study participants 
had to complete the survey to its 
entirety. All study participants joined 
this pilot study voluntarily without 
any form of compensation. 
The new authorities granted by 
SB 493 encompass various areas of 
pharmacy practice. To assess phar-
macists’ self-perceived readiness, 
a series of two to three Likert-scale 
questions was written, originating 
from each new authority. 
Both qualitative and quantitative 
data were collected and downloaded 
to an Excel spreadsheet. Data 
analysis was focused on quantitative 
data, as quantitative data character-
ized the outcome measures from 
this study. To be more specific, the 
Likert-scale scores (1 = Strongly Dis-
agree; 2 = Disagree; 3 = Neutral; 4 = 
Agree; 5 = Strongly Agree) were the 
primary outcomes indicating phar-
macists’ self-perceived readiness 
for each new authority. A Kruskal-
Wallis test, a nonparametric one-
way ANOVA test examining more 
than two unmatched groups, was 
employed to examine Likert-scale 
scores (non-parametric data) among 
the three subgroups [degrees of 
freedom (df) = 2] via the STATA 
13® statistical package. Performing 
a Kruskal-Wallis test on the Likert-
scale data through the indicated 
software generated a critical value 
(H) and a p-value for each question. 
Secondary outcomes included par-
ticipants’ responses relating to the 
survey questions on pharmacists’ 
awareness and knowledge of the 
new authorities.
In our survey, some pre-iden-
tified values that SB 493 might 
provide for the pharmacy profes-
sion were listed, and participants 
were asked if they agreed with 
such statements. The pre-identified 
values were:
•	 Expanding the scope of prac-
tice;
•	 Enhancing the value of 
services provided by pharma-
cists;
•	 Compensating for a shortage 
of PCP;
•	 Maintaining sustainability;
•	 Providing more job satisfac-
tion.
In addition, pre-identified barriers 
that the profession might encounter 
while implementing SB 493 were 
also listed, and study participants 
were then again asked if they agreed 
with such statements. The pre-identi-
fied barriers were:
•	 Reimbursing for new services;
•	 Accessing patients’ medical 
records;
•	 Integration of SB 493 into cur-
rent pharmacy practice;
•	 Additional staffing to provide 
new services;
•	 Additional training needed;
•	 Change in community pharma-
cies’ focus.
Results
Invitations were sent to potential 
681 participants; 62 responses were 
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Table 2. Pharmacists’ Self-Perceived Readiness for New Authorities. 
Survey Items5 Critical  Value (H) p value
Administration of prescribed injectable drugs and biologics
I have received adequate training that allows me to confidently administer drugs for patients 
via oral and topical routes.
0.564 0.7545
I have received adequate training that allows me to confidently administer drugs and biologics 
for patients via injections.
2.144 0.3423
Provision of consultation, training, and education about drug therapy, disease management, and disease 
prevention
I have received adequate training that allows me to provide consultation, training, and 
education about drug therapy confidently.
2.469 0.291
I have received adequate training that allows me to provide consultation, training, and 
education about disease management confidently.
5.692 0.0581
I have received adequate training that allows me to provide consultation, training, and 
education about disease prevention confidently.
3.982 0.1366
Participation in review of patient progress in a multidisciplinary team
I am ready to participate in reviewing the patient’s progress in a multidisciplinary team. 0.13 0.9369
I prefer verifying and dispensing medications over participating in review of patient progress in 
a multidisciplinary team.
4.426 0.1094
I feel I need more training to develop my skills in reviewing patient progress in a 
multidisciplinary team.
3.342 0.188
Furnishing self-administered hormonal contraceptives (the pill, the patch, and the ring) with a statewide protocol
I feel I have acquired adequate training that allows me to dispense emergency contraceptives. 0.241 0.8867
With additional specialized training and a statewide protocol on hormonal contraceptives, I 
am confident that I will be prepared to furnish self-administered hormone contraceptives in 
addition to emergency contraception drug therapy.
1.043 0.5936
Furnishing travel medications recommended by the CDC (without a diagnosis)
I have received adequate training that allows me to furnish travel medications recommended 
by the CDC (not requiring a diagnosis).
1.646 0.439
I am ready to furnish travel medications recommended by the CDC (not requiring a diagnosis). 2.278 0.3202
Furnishing prescription nicotine replacement products for smoking cessation with a statewide protocol
I have received adequate training that allows me to recommend OTC nicotine replacement 
products for smoking cessation.
0.316 0.8538
I feel comfortable in recommending OTC nicotine replacement products for smoking 
cessation.
0.916 0.6325
With additional specialized training in smoking cessation, I am confident that I will be prepared 
to furnish prescription nicotine replacement products for smoking cessation with a statewide 
protocol.
0.512 0.7706
Initiation and administration of immunizations to patients (> 3 years old) without a physician protocol
I am confident and ready to independently initiate and administer immunizations to consumers 
(> 3 years old) without a physician protocol.
8.795 0.0123
I would feel more comfortable providing immunizations to consumers > 3 years old with a 
physician protocol.
5.017 0.0814
Ordering and interpreting tests for the purpose of monitoring and managing drug therapies in coordination with patient’s 
primary care provider
I have received adequate training that allows me to order and interpret tests for the purpose of 
monitoring and managing drug therapies in coordination with patient’s primary care provider.
0.463 0.7933
I feel confident in ordering and interpreting tests for the purpose of monitoring and managing 
drug therapies in coordination with patient’s primary care provider.
0.891 0.6406
Overall
I feel prepared to exercise all the new authorities granted by SB 493. 0.383 0.8259
I am confident that I can integrate new authorities into my practice well. 0.923 0.6303
It is important for my practice to focus on delivering clinical pharmacy services to my patients 0.628 0.7304
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collected, thereby creating a nine-
percent response rate. After exclud-
ing 11 incomplete survey responses, 
51 participant pharmacists’ responses 
were included and analyzed (Table 1). 
Among the subgroups, adjunct faculty 
members had practiced pharmacy the 
longest with an average of 20.9 years 
compared to 11.7 years for clinical fac-
ulty and 1.2 years for alumni. Thirty-
seven percent of the participants 
were inpatient pharmacists, which 
was the largest pharmacist group 
based on pharmacy practice settings.
A Kruskal-Wallis test revealed 
no statistically significant differ-
ence among the three subgroups’ 
self-perceived readiness to exer-
cise the following new authorities: 
prescribing hormonal contraception, 
nicotine replacement products, travel 
medications; obtaining lab results to 
ensure the safety and efficacy of drug 
therapy; administering drugs and bio-
logics; and reviewing patient progress 
(Table 2).
There was a significant difference 
among the three subgroups in terms 
of self-perceived confidence and 
readiness to independently initiate 
and administer immunizations to 
consumers older than 3 years of age 
without practicing under a physi-
cian’s collaborative practice protocol 
[Kruskal-Wallis test: H = 8.795 (df 
= 2, N = 51), p = 0.0123]. Adjunct 
faculty members reported that they 
perceived they were the least ready 
and prepared to provide vaccinations. 
Compared to alumni and adjunct 
faculty, clinical faculty expressed the 
highest self-perceived readiness to 
provide consultation, training, and 
education on disease management. 
Although the Kruskal-Wallis test did 
not reveal a statistically significant 
difference among the three groups 
on exercising this new authority [H = 
5.692 (df = 2, N = 51), p = 0.0581], 
the p-value suggested that self-
perceived readiness on this task was 
trending to be statistically significant 
among the three groups.
All participants reported that they 
were aware of SB 493. Ninety-two 
percent of this cohort reported the 
perception that this new legislature 
was extremely or very important 
for the advancement of the phar-
macy profession. Approximately 
twenty percent of the participants 
were able to recall facts correctly 
in answering questions regarding 
the details of SB 493. Sixty-seven 
percent of the participants reported 
that they had met at least two cri-
teria to become Advanced Practice 
Pharmacists.
 Results regarding perceived val-
ues of SB 493 are showed in Figure 
1, which indicates the percentage 
of participants’ agreeing with the 
pre-identified values. The value that 
received the highest agreement 
rate was “enhancing the value of 
services provided by pharmacists.” 
On the other hand, the value that 
received the lowest agreement rate 
was “maintaining sustainability.” 
Overall, ninety-four percent of the 
participants agreed that SB 493 
would enhance the value of services 
provided by pharmacists, but only 
fifty-one percent agreed that this 
new legislature would help maintain 
the sustainability of the profession in 
California.
Figure 2 shows the percentage of 
participants’ agreeing with several 
pre-identified barriers. The barrier 
that received the highest agreement 
rate was “obtaining reimburse-
ment for providing new services.” 
Eighty-eight percent of the group 
identified obtaining reimbursement 
for the new services as a barrier to 
implementing SB 493, which was 
the highest among all pre-identified 
barriers.
Discussion
Although the results of this pilot 
study provided some insights into 
pharmacists’ awareness of SB 493, 
there were some limitations. The 
biggest drawback was the small 
sample size, which was caused by 
the limited availability of pharma-
cists’ email addresses (selection 
error/bias), low survey response rate 
(sampling error), as well as incom-
plete survey responses (an exclusion 
criterion.
According to the Public Records 
Desk of the Board of Pharmacy, 
the state of California has approxi-
mately 39,000 licensed phar-
macists (38,926 pharmacists on 
10/28/2013).7 With a population size 
of 40,000, a sample size of 380 is 
needed for adequate representa-
tion.8 The goal of the survey is to 
identify the needs for continued 
education regarding exercising the 
newly authorized tasks among regis-
tered pharmacists. Archer suggests 
that needs assessment surveys 
should have about a 40% response 
rate.9 Combining the expected sam-
ple size and response rate stated, 
the expected survey population 
would be 950. Since this study was 
a pilot project, the aim for future 
direction is to expand this study by 
 
96%
89%
82%
43%
82%
100% 100%
93%
60%
73%
63%
100%
63% 63%
75%
Expanding
Scope of
Practice
Enhancing Value
of Services
Provided by
Pharmacists
Compensating
for Shortage of
PCP
Maintaining
Sustainability
Providing More
Job Satisfaction
28 vs. 15 vs. 8
Figure 1. Percent Agreeing with Pre-Identified Values.
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partnering with professional phar-
macy organizations, such as the 
California Pharmacists Association, 
to disseminate the survey to a larger 
population of pharmacists through-
out the state of California.
Touro University California Col-
lege of Pharmacy alumni, adjunct 
faculty, and clinical faculty believe 
that the passage of SB 493 is criti-
cal for the growth of the pharmacy 
profession. Participant pharmacists 
are aware of SB 493, but more 
education is needed on the specific 
provisions of SB 493 in order to be 
successfully implemented in phar-
macy practice. Most of the study 
participants agreed that SB 493 
would enhance the value of services 
provided by pharmacists. 
However, the cohort reported 
that obtaining reimbursement for 
the additional clinical activities 
would be the greatest challenge for 
implementing SB 493. The fact that 
only half of the participants agreed 
that SB 493 would help maintain the 
sustainability of the profession in 
California may be attributed to this 
concern. 
Adjunct faculty as a group 
expressed an unreadiness to inde-
pendently initiate and administer 
immunizations to consumers older 
than 3 years of age without a physi-
cian’s collaborative practice protocol. 
Perhaps fewer of the adjunct faculty 
participant pharmacists have been 
certified as immunizers even though 
they have been in the profession 
the longest, reflecting the need to 
receive additional training to fully 
exercise this specific authority. 
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Survey Instrument 
 
Demographic Characteristics 
 
1. Gender 
a. Male b. Female 
2. Practice site: If you work at multiple sites, please pick the site where you spend the most number of hours per week. 
a. Academia setting (Touro University California) 
b. Ambulatory care setting 1) Community clinic (Clinic Ole, Lifelong) 
2) Governmental health care facility outpatient clinic (Veteran Affair) 
3) Hospital outpatient clinic (Kaiser Permanente) 
c. Community pharmacy setting 
1) Chain community pharmacy (CVS, Rite Aid, Walgreens) 
2) Mass merchandiser pharmacy (Target, Wal-Mart, Costco) 
3) Supermarket pharmacy (Safeway, Raley’s) 
4) Independent pharmacy (Golden Gate Pharmacy) 
5) Mail-order pharmacy (TRICARE, Medco, Caremark) 
6) Internet pharmacy 
d. Industrial setting: Drug development and manufacturer (TEVA) 
e. Inpatient pharmacy setting 1) < 100-bed hospital 
2) 100-to-200-bed hospital 
3) > 200-bed hospital 
f. Other: ________ 
3. Years of experience: How many years have you been working as a registered pharmacist? 
a. ______ years of pharmacist experience 
4. Highest level of training a. Earned specialized or board certification(s) 
b. Completed a residency  
c. Earned a PharmD  
d. Earned a BS in pharmacy  
e. Foreign graduate  
5. Pharmacist position a. Pharmacy director  
b. Pharmacy manager 
c. Staff pharmacist  
d. Floating pharmacist or per-diem pharmacist 
e. Clinical pharmacist 
f. Other 
6. Employment status: If you have multiple jobs, please pick the job where you spend the most number of hours per week.  
a. Full time  b. Part time c. Retired 
7. Geographical regions (work): If you work at multiple regions, please pick the region where you spend the most number of hours per week.  
a. Northern California  
b. Northern Sacramento Valley  
c. Greater Sacramento  
d. San Francisco Bay Area  
e. Central Coast  f. San Joaquin Valley  
g. Central Sierra Region  
h. Southern California  
i. Southern Border  
 
Awareness of New Authorities Provided by SB 493 
 
1. Have you heard of SB 493? 
a. Yes …….. Move to Question 2 
b. No ……... Skip to next section 
2. How did you find out about SB 493? (Check all that apply) 
a. Board of Pharmacy 
b. Pharmacy professional organizations (CSHP, CPhA) 
c. Employer or co-workers 
d. Newsletters e. News articles f. Continuing education programs 
g. Other: _________  
 
 
 
3. From what y
ou have heard or
 read, which of th
e following is true
 regarding SB 49
3? (Check all tha
t apply) 
a. Declares ph
armacists’ health
 care-provider sta
tus 
b. Authorizes a
ll licensed pharm
acists certain aut
horities which pre
viously were only
 limited to inpatie
nt settings 
c. Establishes
 an Advanced Pr
actice Pharmacis
t (APP) recognitio
n 
d. Becomes ef
fective on March
 1, 2014 
e. Requires ph
armacists to obta
in additional train
ing in order to ex
ercise the grante
d authorities 
4. From what 
you have heard a
nd read, what ar
e the newly gran
ted authorities pr
ovided by SB 49
3 to all registered
 pharmacist? (Ch
eck all that 
apply) 
a. Furnish trav
el medications re
commended by C
DC 
b. Order tests 
for diagnostic pu
rposes 
c. Initiate and 
administer immu
nizations to all pa
tients regardless
 of age 
d. Furnish self
-administered ho
rmonal contracep
tives with a state
wide protocol 
e. Prescribe p
rescription medic
ations 
f. Administer p
rescribed drugs a
nd biologics 
g. Furnish pre
scription nicotine
 replacement pro
ducts for smoking
 cessation with o
r without a protoc
ol 
h. Order tests 
for medication-re
gimen monitoring
 purposes 
5. What is you
r opinion about th
e importance of S
B 493 in the phar
macy profession?
 
a. Extremely im
portant 
b. Very import
ant 
c. Somewhat i
mportant 
d. Neither imp
ortant nor unimpo
rtant 
e. Somewhat u
nimportant 
f. Very unimp
ortant 
g. Not at all im
portant 
h. Too early to
 tell 
6. Why do you
 think SB 493 is b
eneficial for the f
uture of the phar
macy profession 
in California? (Ch
eck all that apply
) 
a. Expanding a
nd re-focusing th
e scope of pharm
acists’ practice in
 California 
b. Enhancing t
he value of pharm
acists’ profession
al services in pat
ient care 
c. Compensat
ing for the shorta
ge of primary car
e providers in Ca
lifornia 
d. Providing m
ore opportunities
 to maintain susta
inability (e.g., ind
ependent pharma
cies) 
e. Providing m
ore job satisfactio
ns to California p
harmacists 
f. Other: ____
__________  
 
Interest in Becom
ing an Advanced
 Practice Pharma
cist (APP) 
 
1. In order to b
e recognized as 
an APP, a pharm
acist must meet t
wo of the three c
riteria listed below
. How many of th
e following requir
ements do 
you meet? (Chec
k all that apply) 
a. Earning a c
ertification in a re
levant area of pra
ctice, such as am
bulatory care, cri
tical care, oncolo
gy pharmacy or p
harmacotherapy.
 
b. Completing
 a postgraduate r
esidency program
 from an accredit
ed postgraduate 
institution. 
c. Having prov
ided clinical serv
ices to patients fo
r one year under
 a collaborative p
ractice agreemen
t or protocol with
 a physician, APP
, 
CDTM pharmacis
t, or health syste
m. 
2. If you have 
met two or more 
requirements abo
ve, are you intere
sted in becoming
 an APP? 
a. Yes 
b. Maybe 
c. No 
d. I have not m
et two or more cr
iteria at this point
. 
3. If you have 
not met two or m
ore requirements
 at this point, are
 you interested in
 getting more trai
ning to meet the 
requirements and
 become an 
APP? 
a. Yes 
b. No 
c. Undecided 
 
Readiness for Ne
w Authorities Pro
vided by SB 493
 
 
Note: Please ind
icate in the chart
 below regarding
 your readiness t
o provide the ser
vices described i
n the bolded sec
tions. 
Survey Items 
Strongly 
Disagree 
Disagree N
eutral Ag
ree Stron
gly 
Agree 
Administration o
f prescribed inje
ctable drugs and
 biologics 
1. I have recei
ved adequate tra
ining that allows 
me to 
confidently admin
ister drugs for pa
tients via oral and
 topical 
routes. 
  
  
 
2. I have recei
ved adequate tra
ining that allows 
me to 
confidently admin
ister drugs and b
iologics for patien
ts via 
injections. 
  
  
 
Provision of con
sultation, trainin
g, and education
 about drug ther
apy, disease ma
nagement, and d
isease preventio
n 
1. I have recei
ved adequate tra
ining that allows 
me to provide 
consultation, train
ing, and educatio
n about drug ther
apy 
confidently. 
  
  
 
2. I have recei
ved adequate tra
ining that allows 
me to provide 
consultation, train
ing, and educatio
n about disease 
management con
fidently. 
  
  
 
3. I have recei
ved adequate tra
ining that allows 
me to provide 
consultation, train
ing, and educatio
n about disease 
prevention 
confidently. 
  
  
 
Participation in r
eview of patient 
progress in a mu
ltidisciplinary tea
m 
 
1. I am ready to participate in reviewing patient’s progress in a 
multidisciplinary team.      
2. I prefer verifying and dispensing medications over 
participating in review of patient progress in a multidisciplinary 
team.      
3. I feel I need more training to develop my skills in reviewing 
patient progress in a multidisciplinary team.      
Furnishing self-administered hormonal contraceptives (the pill, the patch, and the ring) with a statewide protocol 
1. I feel I have acquired adequate training that allows me to 
dispense emergency contraceptives.      
2. With additional specialized training and a statewide protocol 
on hormonal contraceptives, I am confident that I will be 
prepared to furnish self-administered hormone contraceptives 
in addition to emergency contraception drug therapy. 
     Furnishing travel medications recommended by the CDC (without a diagnosis) 
1. I have received adequate training that allows me to furnish 
travel medications recommended by the CDC (not requiring a 
diagnosis).      
2. I am ready to furnish travel medications recommended by the 
CDC (not requiring a diagnosis).      
Furnishing prescription nicotine replacement products for smoking cessation with a statewide protocol 
1. I have received adequate training that allows me to 
recommend OTC nicotine replacement products for smoking 
cessation.      
2. I feel comfortable in recommending OTC nicotine replacement 
products for smoking cessation.      
3. With additional specialized training in smoking cessation, I am 
confident that I will be prepared to furnish prescription nicotine 
replacement products for smoking cessation with a statewide 
protocol. 
     Initiation and administration of immunizations to patients (> 3 years old) without a physician protocol 
1. I am confident and ready to independently initiate and 
administer immunizations to consumers (> 3 years old) 
without a physician protocol. 
     
2. I would feel more comfortable providing immunizations to 
consumers > 3 years old with a physician protocol.      
Ordering and interpreting tests for the purpose of monitoring and managing drug therapies in coordination with patient’s primary care 
provider 
1. I have received adequate training that allows me to order and 
interpret tests for the purpose of monitoring and managing 
drug therapies in coordination with patient’s primary care 
provider. 
     2. I feel confident in ordering and interpreting tests for the 
purpose of monitoring and managing drug therapies in 
coordination with patient’s primary care provider. 
     
Overall 
1. I feel prepared to exercise all the new authorities granted by 
SB 493. 
     
2. I am confident that I can integrate new authorities into my 
practice well. 
     
3. It is important for my practice to focus on delivering clinical 
pharmacy services to my patients.      
 
Barriers of Implementing SB 493  
1. What do you perceive as some of the barriers to fully implement SB 493? (Check all the apply) 
a. Being able to bill for the new services provided  
b. Obtaining access to patients’ medical information (e.g., past medical history and laboratory results)  
c. Integrating SB 493 into individual pharmacy company’s policies and operations 
d. Additional staffing needed to provide additional services  
e. Additional training required before exercising new authorities into individual pharmacist’s daily practice 
f. Community pharmacists’ change in practice focus from product-centered to service/patient-centered 
g. Other: 
a) State level barrier(s): ___________________ 
b) Organizational level barrier(s): ________________ 
c) Individual level barrier(s): _____________ 
 
 
Additional Comments   
Note: Please use the space provided below to express your thoughts on SB 493. 
 
 
 
 
Survey 
Instrument
